The American Journal of Medicine
Volume 28, Issue 5 , Pages 777-793 , May 1960

The clinical management of leukemia

  • Arthur Haut, M.D.

      Affiliations

    • From the Department of Internal Medicine, University of Utah, College of Medicine, Salt Lake City, Utah.
    • John and Mary Markle Scholar in Medical Science.
    • ,
  • Maxwell M. Wintrobe, M.D.

      Affiliations

    • From the Department of Internal Medicine, University of Utah, College of Medicine, Salt Lake City, Utah.
    • ,
  • G.E. Cartwright, M.D.

      Affiliations

    • From the Department of Internal Medicine, University of Utah, College of Medicine, Salt Lake City, Utah.

References 

  1. Downey H. In: 4th ed.. Handbook of Hematology. New York: Paul B. Hoeber; 1938;
  2. Wintrobe MM. Clinical Hematology. In: 4th ed.. Philadelphia: Lea & Febiger; 1956;p. 942
  3. Raab, S., Hoeprich, P. D., Wintrobe, M. M. and Cartwright, G. E. The clinical significance of fever in acute leukemia. Blood, to be published.
  4. Scott RB. Leukaemia. Lancet. 1957;1:1053Scott RB. Leukaemia. Lancet. 1957;1:1099Scott RB. Leukaemia. Lancet. 1957;1:1162
  5. Freireich EJ, Schmidt PJ, Schneiderman MA, Frei E. A comparative study of the effect of transfusion of fresh and preserved whole blood on bleeding in patients with acute leukemia. New England J. Med. 1959;260:6
  6. McGovern JJ. Platelet transfusions in pediatrics. New England J. Med. 1957;256:922
  7. Klein E, Farber S, Djerassi I, Toch R, Freedman G, Arnold P. The preparation and clinical administration of lyophilized platelet material to children with acute leukemia and aplastic anemia. J. Pediat. 1956;49:517
  8. Jackson DP, Sorensen DK, Cronkite EP, Bond VP, Fliedner TM. Effectiveness of transfusions of fresh and lyophilized platelets in controlling bleeding due to thrombocytopenia. J. Clin. Invest. 1959;38:1689
  9. Connor WE, Carter JR. Influence of soybean phosphatide on blood coagulation and its use in the thromboplastin generation test. In: Proc. Soc. Exper. Biol. & Med. 97:1958;p. 38
  10. Birnbaum W, Ahlquist R. Rectal infections and ulcerations associated with blood dyscrasias. Am. J. Surg. 1955;90:367
  11. Haut A, Altman SJ, Cartwright GE, Wintrobe MM. The use of myleran in the treatment of chronic myelocytic leukemia. Arch. Int. Med. 1955;96:451
  12. Reinhard EH, Neely GL, Samples DM. Radioactive phosphorus in the treatment of chronic leukemias: long-term results over a period of 15 years. Ann. Int. Med. 1959;50:942
  13. Fessas P, Wintrobe MM, Thompson RB, Cartwright GE. Treatment of acute leukemia with cortisone and corticotropin. Arch. Int. Med. 1954;94:384
  14. Farber S, et al. Action of pteroylglutamic conjugates on man. Science. 1947;106:619
  15. Bessis M, Dausset J. Etude critique des rémissions au cours des leucémies aigues traitées par exsanguino-transfusions. Rev. d'hémat. 1950;5:188
  16. Osgood EE, Seaman AJ, Koler RD. Results of 15-year program of treatment of chronic leukemias with titrated regularly spaced total body irradiation with phosphorus 32 or x-ray. In: Proceedings of the International Society of Hematology, (Sixth International Congress). New York: Grune & Stratton; 1958;p. 44
  17. Haut, A., Abbott, W. S., Wintrobe, M. M. and Cartwright, G. E. Busulfan in the long term therapy of chronic myelocytic leukemia. To be submitted for publication.
  18. Lawrence JH. The treatment of chronic leukemia. M. Clin. North America. 1954;38:525
  19. Lawrence JH, Dobson RL, Low-Beer BVA, Brown BR. Chronic myelogenous leukemia. A study of 129 cases in which treatment was with radioactive phosphorous. J. A. M. A. 1948;136:672
  20. Galton DAG. The use of myleran and similar agents in chronic leukemias. In:  Greenstein JP,  Haddow A editor. Advances in Cancer Research. vol. 4:New York: Academic Press, Inc; 1956;p. 73
  21. Cartwright GE, Sandberg AA, Wintrobe MM. Uric acid excretion by patients with various types of leukemia. In: Proceedings of the Third National Cancer Conference. Philadelphia: J. B. Lippincott; 1957;p. 357
  22. Sandberg AA, Cartwright GE, Wintrobe MM. Studies on leukemia. I. Uric acid excretion. Blood. 1956;11:154
  23. Kritzler RA. Anuria complicating the treatment of leukemia. Am. J. Med. 1958;25:532
  24. Schlosser JV. Irradiation therapy of leukemia. In: Etiology and Treatment of Leukemia.  Burdette WJ editors. Proceedings of the First Louisiana Cancer Conference. St. Louis: C. V. Mosby; 1958;p. 98
  25. Karnofsky DA. The management of leukemia in adults. New York State J. Med. 1954;54:3225
  26. Osgood EE, Seaman AJ. Treatment of chronic leukemias. J. A. M. A. 1952;150:1372
  27. Easson EC. A quantitative study of the radiosensitivity of chronic leukaemia. Brit. J. Radiol. 1957;30:35
  28. Till M. The use of chlorambucil (CB 1348) and busulfan (myleran) in the treatment of leukemia. In: Etiology and Treatment of Leukemia.  Burdette WJ editors. Proceedings of the First Louisiana Cancer Conference. St. Louis: C. V. Mosby; 1958;p. 102
  29. Schilling RF, Meyer OO. Treatment of chronic granulocytic leukemia with 1, 4-dimethanesulfonyloxybutane (myleran). New England J. Med. 1956;254:986
  30. Turesson D. Myleran treatment in chronic granulocytic leukaemia. Brit. J. Haemat. 1957;3:220
  31. Unugur A, Schulman E, Dameshek W. Treatment of chronic granulocytic leukemia with myleran. New England J. Med. 1957;256:727
  32. Galton DAG. Treatment of the chronic leukaemias. Brit. M. Bull. 1959;15:78
  33. Moeschlin S. Round-table discussion on therapy. In:  Rebuck JW,  Bethelland FH,  Monto RW editor. The Leukemias: Etiology, Pathophysiology, and Treatment (Henry Ford Hospital International Symposium). New York: Academic Press, Inc; 1957;p. 645
  34. Leonard BJ, Wilkinson JF. Desacetyl-methylcolchicine in treatment of myeloid leukaemia. Brit. M. J. 1955;1:874
  35. Burchenal JH, Ellison RR. Chemotherapy of human leukemia. In: Progress in Hematology. New York: Grune & Stratton; 1956;p. 265
  36. Krakoff IH, Karnofsky DA, Burchenal JH. Remissions induced by chlorambucil in chronic granulocytic leukemia. J. A. M. A. 1958;166:629
  37. Miller DG, Diamond HD, Craver LF. A critical study of the clinical use of chlorambucil. New England J. Med. 1959;261:525
  38. Rundles RW, et al. Comparison of chlorambucil and Myleran® in chronic lymphocytic and granulocytic leukemia. Am. J. Med. 1959;27:424
  39. Moffitt HC, Lawrence JH. Chronic leukemia of long duration: with a report of 31 cases with a duration of over five years. Ann. Int. Med. 1949;30:778
  40. Tivey H, Moffat CA. The prognosis for survival in chronic granulocytic and lymphocytic leukemia. Am. J. Roentgenol. 1954;72:68
  41. Shay H, Zarafonetis C, Smith N, Woldow I, Sun DCH. Treatment of leukemia with triethylene thiophosphoramide (thio-TEPA). Arch. Int. Med. 1953;92:628
  42. Zarafonetis CJD, Shay H, Sun DCH. Triethylenethiophosphoramide in the treatment of chronic leukemia. Cancer. 1955;8:512
  43. Sykes MP, Philips FS, Karnofsky DA. Comparative therapeutic activity of the nitrogen mustards and allied compounds. M. Clin. North America. 1956;40:837
  44. Ultmann JE, Hyman GA, Crandall C, Naujoks H, Gellhorn A. Triethylenethio-phosphoramide (Thio-TEPA) in the treatment of neoplastic disease. Cancer. 1957;10:902
  45. Rottino A. Therapeutic results in treatment of Hodgkin's disease with CB 1348 and R-48. Blood. 1957;12:755
  46. Bouroncle BA, Doan CA, Wiseman BK, Frajola WJ. Evaluation of CB 1348 in Hodgkin's disease and allied disorders. Arch. Int. Mcd. 1956;97:703
  47. Galton DAG, Israels LG, Nabarro JDN, Till M. Clinical trials of p-(DI-2-chloroethylamino)-phenylbutyric acid (CB 1348) in malignant lymphoma. Brit. M. J. 1955;2:1172
  48. Bethell FH, Meyers MC, Bishop RC, Spencer HH. Advances in the treatment of leukemia. J. Michigan State M. Soc. 1959;58:614
  49. Koler RD, Forsgren AL. Hepatotoxicity due to chlorambucil. J. A. M. A. 1958;167:316
  50. Wolfson S, Olney MB. Accidental ingestion of a toxic dose of chlorambucil. J. A. M. A. 1957;165:239
  51. Axelrod AR, Berman L, Murphy RV. Clinical and hematologic effects of triethylene melamine. Am. J. Med. 1953;15:684
  52. Karnofsky DA, et al. Triethylene melamine in the treatment of neoplastic disease. Arch. Int. Med. 1951;87:477
  53. Karnofsky DA. Triethylene melamine in the treatment of lymphomas and leukemias. M. Clin. North America. 1954;38:541
  54. Gellhorn A, Kligerman MM, Jaffe I. Triethylene melamine in clinical cancer chemotherapy. Am. J. Med. 1952;13:428
  55. Slipyan A. Unusual toxicity to triethylene melamine in a case of chronic myelogenous leukemia. Ann. Int. Med. 1953;38:331
  56. Haut A, Altman SJ, Wintrobe MM, Cartwright GE. The influence of chemotherapy on survival in acute leukemia. Comparison of cases treated during 1954 to 1957 with those treated during 1947 to 1954. Blood. 1959;14:828
  57. Farber S. Round-table discussion on therapy. In:  Rebuck JW,  Bethell FH,  Monto RW editor. The Leukemias: Etiology, Pathophysiology, and Treatment (Henry Ford Hospital International Symposium). New York: Academic Press, Inc; 1957;
  58. Burchenal JH. Treatment of leukemia. In: Etiology and Treatment of Leukemia.  Burdette WJ editors. Proceedings of the First Louisiana Cancer Conference. St. Louis: C. V. Mosby; 1958;p. 109
  59. Hyman CB, Sturgeon P. Prednisone therapy of acute lymphatic leukemia in children. Cancer. 1956;9:965
  60. Granville NB, Rubio F, Unugur A, Schulman E, Dameshek W. Treatment of acute leukemia in adults with massive doses of prednisone and prednisolone. New England J. Med. 1958;259:207
  61. Ranney HM, Gellhorn A. The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas. Am. J. Med. 1957;22:405
  62. Hill JM. Round-table discussion on therapy. In:  Rebuck JW,  Bethell FH,  Monto RW editor. The Leukemias: Etiology, Pathophysiology, and Treatment (Henry Ford Hospital International Symposium). New York: Academic Press, Inc; 1957;p. 629
  63. Gellhorn A. Round-table discussion on therapy. In:  Rebuck JW,  Bethell FH,  Monto RW editor. The Leukemias: Etiology, Pathophysiology, and Treatment (Henry Ford Hospital International Symposium). New York: Academic Press, Inc; 1957;p. 635
  64. Hyman CB, Borda CE, Digumarthi G. What are normal blood values for leukemia in remission?. Blood. 1959;14:369
  65. Ellison RR, Silver RT, Engle RL. Comparative study of 6-chloropurine and 6-mercaptopurine in acute leukemia in adults. Ann. Int. Med. 1959;51:322
  66. McIlvanie SJ, MacCarthy JD. Hepatitis in association with prolonged 6-mercaptopurine therapy. Blood. 1959;14:80
  67. Colsky J, Greenspan EM, Warren TN. Hepatic fibrosis in children with acute leukemia after therapy with folic acid antagonists. Arch. Path. 1955;59:198
  68. Endicott KM. The chemotherapy program. J. Nat. Cancer Inst. 1957;19:275
  69. Hall BE, Willet FM, Hales DR, Feicht-Meir TV, Jerner PW, Franco J. Experience with 6-methylmercaptopurine in the treatment of human acute leukemia. In: Proc. Am. A. Cancer Res. 2:1957;p. 210
  70. Goldin A, Venditti JM, Humphreys SR, Mantel N. Comparison of the relative effectiveness of folic acid congeners against advanced leukemia in mice. J. Nat. Cancer Inst. 1957;19:1133
  71. Humphreys SR, Goldin A. Investigation of tumor variants recovered from mice with systemic leukemia (L-1210) after extensive therapy with 3′,5′-dichloroamethopterin and 3′-bromo-5′-chloroamethopterin. J. Nat. Cancer Inst. 1959;23:633
  72. Burchenal JH, Murphy ML, Tan CTC. Treatment of acute leukemia. Pediatrics. 1956;18:643
  73. Frei E, et al. A comparative study of two regimens of combination chemotherapy in acute leukemia. Blood. 1958;13:1126
  74. Curreri AR, Ansfield FJ, McIver FA, Waisman HA, Heidelberger C. Clinical studies with 5-fluorouracil. Cancer Res. 1958;18:478
  75. In: Cancer Chemotherapy Reports, No. 2. Bethesda, Maryland: Cancer Chemotherapy National Service Center; March 1959;
  76. D'Angio GJ, Evans AE, Mitus A. Roentgen therapy of certain complications of acute leukemia in childhood. Am. J. Roentgenol. 1959;82:541
  77. Atkinson JB, Mahoney FJ, Schwartz IR, Hesch JA. Therapy of acute leukemia by whole-body irradiation and bone marrow transplantation from an identical normal twin. Blood. 1959;14:228
  78. Thomas ED, et al. Supralethal whole body irradiation and isologous marrow transplantation in man. J. Clin. Invest. 1959;38:1709
  79. Gross L. Viral etiology of “spontaneous” mouse leukemia: a review. Cancer Res. 1958;18:371
  80. Friend C. Cell-free transmission in adult Swiss mice of a disease having the character of a leukemia. J. Exper. Med. 1957;105:307
  81. Dmochowski L, et al. Studies on human leukemia. In: Proc. Soc. Exper. Biol. & Med. 101:1959;p. 686
  82. Schwartz SO, Schoolman HM. The etiology of leukemia: the status of the virus as causative agent—a review. Blood. 1959;14:279
  83. Bergol'ts VM. An experimental study of the aetiology of the human leukaemias. II. The effect of treatment with formalin and glycerol, of high temperatures and radiant energy on the activity of human leukaemic factor. Probl. gematol. i pereliv. krovi. 1959;4:20Bergol'ts VM. Abstracted in Problems Hemat. & Blood Transfusion. 1959;4:19
  84. Schwartz SO, Schoolman HM, Spurrier W. Studies in leukemia. IX. The induction of leukemia in adult C3H mice by means of cell-free brain filtrates. J. Lab. & Clin. Med. 1959;53:233
  85. Kirschbaum A. Discussion—laboratory, clinical approaches to leukemia chemotherapy. In: Etiology and Treatment of Leukemia.  Burdette WJ editors. Proceedings of the First Louisiana Cancer Conference. St. Louis: C. V. Mosby; 1958;p. 91
  86. Cramblett HG. Recognition and treatment of intracranial manifestations of leukemia. J. Dis. Child. 1959;97:805
  87. Whiteside JA, et al. Intrathecal amethopterin in neurological manifestations of leukemia. Arch. Int. Med. 1958;101:279
  88. Murphy ML. Leukemia and lymphoma in children. Pediat. Clin. North America. 1959;6:611
  89. Cramblett HG, Friedman JL, Najjar S. Leukemia in an infant born of a mother with leukemia. New England J. Med. 1958;259:727
  90. Sheehy TW. An evaluation of the effect of pregnancy on chronic granulocytic leukemia. Am. J. Obst. & Gynec. 1958;75:788
  91. Izumi HM. Myleran in pregnancy, report of a case. J. A. M. A. 1956;161:969
  92. Sherman JL, Locke RV. Use of busulfan in myelogenous leukemia during pregnancy. New England J. Med. 1958;259:288
  93. Diamond I, Anderson MM, McCreadie SR. Transplacental transmission of busulfan (Myleran®) in a mother with leukemia. Production of fetal malformation and cytomegaly. Pediatrics. 1960;25:85

☆ Investigations by the authors to which reference is made in this article were supported by a research grant (CY-2349) from the National Cancer Institute and by a graduate training grant (2A-5098) from the National Institute of Arthritis and Metabolic Diseases, National Institutes of Health, U. S. Public Health Service.

PII: 0002-9343(60)90134-0

The American Journal of Medicine
Volume 28, Issue 5 , Pages 777-793 , May 1960

Article Tools